Evidence map›Paper›PMID 42879032›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Chromatin Immunoprecipitation Followed by Next-Generation Sequencing in Ewing Sarcoma.

Pablo Táboas, Enrique Blanco, Luciano Di Croce, Sara Sánchez-Molina

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pablo TáboasPediatric Cancer, Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat (Barcelona), Spain.
Enrique BlancoCenter for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Luciano Di CroceCenter for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
Sara Sánchez-MolinaPediatric Cancer, Institut de Recerca Sant Joan de Déu (IRSJD), Esplugues de Llobregat (Barcelona), Spain. sara.sanchezm@sjd.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is a widely used technique to study the distribution of transcription factors, histones, posttranslational modifications, or other DNA-associated proteins across the genome. This methodology is based on the isolation of DNA fragments bound by the protein of interest using specific antibodies. Computational analysis of sequencing libraries derived from the isolated DNA fragments will delineate genome-wide maps of protein-DNA interactions. ChIP-seq profiling of EWSR1::FLI1 oncogene has enormously contributed to the understanding of gene reprogramming in Ewing Sarcoma (EwS) defining EWSR1::FLI1 bound sites, the GGAA microsatellites, and the direct targets regulated by the translocation. ChIP-seq methodology has also provided novel biological insight into the proteins contributing to chromatin remodeling as well as the histone modification patterns associated with EWSR1::FLI1 genome-wide. This protocol provides detailed steps on how to conduct quantitative ChIP-seq experiments in EwS cell lines incorporating spike-in controls along with the core of a bioinformatic framework to analyze the results and infer novel biological knowledge.

Indexed as

Chromatin ImmunoprecipitationChromatin Immunoprecipitation SequencingHigh-Throughput Nucleotide SequencingSarcoma, EwingCell Line, TumorHumansOncogene Proteins, FusionRNA-Binding Protein EWSOncogene Proteins, FusionRNA-Binding Protein EWSChromatin immunoprecipitationGenome mappingPeak callingSequencingSonicationSpike-in normalization

Identifiers

PMID42879032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.